Posts in IP News

Other Barks & Bites for Friday, November 20: AG Medina Says Personal Data is Payment for Social Media Use; U.S. Copyright Office Reduces Certain Fee Increases; and WIPO IP Indicators Report Says AI May Be Influencing Filings

This week in Other Barks & Bites: the U.S. Copyright Office issues its final rule on agency fees reducing proposed fee increases for certain group registrations and paper notices of termination; Anthropic stock falls 10% the day after its IPO as part of a bad week for tech stocks; the Sixth Circuit affirms the cancellation of trademark damages as an impermissible double recovery in a trade secret case against Ford; and more.

CAFC Affirms Dismissals of Patent Infringement Lawsuits Against Apple, Amazon Web Services and Netflix

The U.S. Court of Appeals for the Federal Circuit (CAFC), in two rulings issued today in Touchmusic Entertainment LLC v. Netflix, Inc. and Touchmusic Entertainment LLC v. Apple Inc. and Amazon Web Services, Inc., affirmed decisions of the U.S. District Court for the Northern District of Illinois dismissing infringement claims Ziklag IP LLC asserted on an expired patent. In the Netflix appeal, the CAFC found no abuse of discretion in the district court’s refusal to allow Ziklag to return the original patent owner, Touchmusic, to the case. In the two appeals involving Apple and Amazon Web Services, Inc. (AWS), the CAFC held that Ziklag was collaterally estopped from contesting a ruling that it never received the right to sue for past damages.

PERA: Where Patent Law and Healthcare Issues Collide

U.S. Supreme Court opinions in Mayo Collaborative Services v. Prometheus Laboratories, Inc., Association for Molecular Pathology v. Myriad Genetics, Inc., and Alice Corporation Pty. Ltd. V. CLS Bank International et al., produced significant challenges to and unpredictability in obtaining and enforcing patent protection in areas including precision medicine, diagnostics, AI, and pharmaceutical treatments. The Patent Eligibility Restoration Act of 2025 (PERA), S. 1546 and the identical H.R. 3152, seek to address these challenges by rewriting 35 U.S.C. § 101 to eliminate all of these “judicial exceptions to patent eligibility.”

Enforcing IP Rights in Brazil: Why Litigation Is Not Always the First Step

For foreign companies holding trademarks, patents, industrial designs, or other intellectual property assets in Brazil, detecting an infringement can trigger an almost automatic reaction: filing a lawsuit. Although resorting to the courts is an important tool for protecting intellectual property rights, it does not necessarily need to be the first step.

AI and Drug Patents: Are Super-Fast Followers a Threat to Pharmaceutical Innovation? | IPWatchdog Unleashed

This week on IPWatchdog Unleashed, I spoke with Emily Johnson, Nicholas Lanzatella, Kwame Mensah, and Corey Salsberg. This conversation took place on November 9, 2026, at IPWatchdog Studios at the fifth annual Life Sciences Masters™ conference. We examine how artificial intelligence is changing life sciences research and patent strategy. Our focus was on the emergence of super-fast followers, who are competitors positioned to quickly analyze published inventions and rapidly pursue related candidates and patent filings. For an industry built on expensive, uncertain research, the implications reach well beyond faster drafting or more efficient discovery. At stake is the balance between accelerating the development of new medicines and preserving the economic incentives that make pioneering discoveries possible in the first place.

CAFC Vacates Finding of Non-Infringement Due to District Court’s Failure to Resolve Claim Construction Dispute

The U.S. Court of Appeals for the Federal Circuit (CAFC) on Wednesday vacated a judgment of no infringement and affirmed a validity finding for patent owner Edge Systems LLC. The nonprecedential opinion was authored by Judge Prost and joined by Judges Hughes and Cunningham.

AI-assisted SEP Prosecution to Build Portfolios for Licensing, Sale, or Enforcement

Standard-essential patents (SEPs) are among the most valuable assets in today’s technology economy. They form the foundation of licensing programs, determine competitive positioning, and increasingly become the center of high-stakes litigation across multiple jurisdictions. Yet one reality remains unchanged: many SEPs that initially appear to be strong eventually fail when scrutinized in court.

Federal Circuit Affirms Indefiniteness of Breathable Membrane Patent Claims Over Unspecified Measurement Method

The U.S. Court of Appeals for the Federal Circuit (CAFC) issued a precedential decision Tuesday in Cocona, Inc. v. VF Outdoor, LLC, affirming a judgment of the U.S. District Court for the District of Colorado that held three claims of a waterproof, breathable membrane patent invalid as indefinite. Circuit Judge Stark wrote for the court, joined by Circuit Judges Lourie and Stoll, and agreed with the district court that the asserted claims recited a numerical range for moisture vapor transmission rate (MVTR) without specifying a method for measuring it.

Patents Pitted Against PBMs in Senate Judiciary Hearing on U.S. Drug Prices

The full Senate Judiciary Committee today heard from five witnesses who urged senators to take action to curb pharmaceutical industry and pharmacy benefit manager (PBM) practices, which they alternately blamed for high U.S. drug costs. While some senators warned that targeting drug makers could have unintended consequences, most supported moving quickly on legislation they claim would lower prices for U.S. consumers, a claim industry has called a “myth”.

Solutions Still in Search of a Problem: Seeing Through False Narratives on Patents on Medicines

Critics of the pharmaceutical patent system often claim that manufacturers use large patent portfolios to delay competition. A new paper in the Journal of Law and the Biosciences offers the latest version of that argument, focusing specifically on biologics. The authors compare biologic patent portfolios in the United States, Europe, and Japan. They find that the largest patent portfolios are in the United States—and that biologics are associated with more patents than traditional small-molecule drugs. This may be true, but it does not demonstrate that a problem exists. 

CAFC Orders Dismissal of Patent Owner’s Independent Action Seeking to Void Verizon Fee Award

The U.S. Court of Appeals for the Federal Circuit (CAFC) issued a precedential decision on Monday in Traxcell Technologies, LLC v. Cellco Partnership, dba Verizon Wireless, vacating a judgment of the U.S. District Court for the Western District of Texas and remanding with instructions to dismiss Traxcell’s independent action for lack of jurisdiction. Traxcell brought the action seeking to void an attorneys’ fee award that the U.S. District Court for the Eastern District of Texas granted to Verizon under 35 U.S.C. Section 285, an award the CAFC had previously affirmed.

Gilead Wins $69 Million Damages, Permanent Injunction Against Defaulting Defendants in HIV Counterfeiting Ring

Last Friday, U.S. District Judge Natasha Merle of the Eastern District of New York entered an order adopting a U.S. magistrate judge’s report and recommendation to grant Gilead Sciences’ motion for default judgment against eight individuals and 18 shell companies involved in a conspiracy to market counterfeit HIV treatments, many of them improperly labelled and sold with falsified chain-of-sale documents.

Corning is Seeking an IP Counsel, Optical Communications

Advance Corning’s Intellectual Property position in optical connectivity by delivering high-quality patent portfolio development and management, IP risk assessments, and IP-related counseling on non-disclosure agreements, trade secrets, and related information protection matters, leveraging AI-enabled tools to drive efficiency, quality, and continuous improvement in how IP work is performed. This is a full-time, permanent position based in Charlotte, NC, with the option to work in a hybrid or fully in-person capacity. Relocation assistance may be available for qualified candidates who are open to relocating to the Charlotte, NC area.

Judge Newman’s Challenge: Don’t Just Navigate Patent Law—Change It | IPWatchdog Unleashed

Uncertainty in patent rights undermines the investment needed to turn scientific breakthroughs into commercial products—but accepting that uncertainty is a choice. In this episode of IPWatchdog Unleashed, Judge Pauline Newman draws on her experience in industry and the policy discussions that helped shape the Federal Circuit to connect today’s life sciences challenges with the conditions that drove an earlier era of patent reform. She explains why predictable, reliable patent protection matters to research investment, commercialization, and the ability to recover the costs of failed research as well as successful discoveries. Her message to IP counsel, industry leaders, and policymakers is direct: addressing the weaknesses of the patent system requires looking beyond how to navigate existing law and engaging in the work of changing it.

SCOTUS Denies Two Petitions Challenging Federal Circuit’s Section 101 Analysis for Computer-Related Inventions

Today, the U.S. Supreme Court issued an order list including denials of a pair of petitions for writ of certiorari challenging subject matter eligibility analyses under 35 U.S.C. § 101 by the U.S. Court of Appeals for the Federal Circuit. These denials continue the Court’s trend of ignoring loud alarms raised regarding the Federal Circuit’s application of the Court’s two-step patentability test under Alice Corp. v. CLS Bank International, especially the intra-circuit development of conflicting standards for analyzing subject matter eligibility of computer-related inventions.

Varsity Sponsors

From the IPWatchdog Institute

IPWatchdog Events

From IPWatchdog